Our American teams have worked tirelessly alongside Emmyon, Inc. to offer an innovative ursolic acid-based solution that supports muscle health in dogs. Full details of this partnership and the resulting product can be found in the press release issued on January 07, 2025. 

Strong annual revenue growth of +13.6% supported by dynamic organic growth (+7.5%) and the strategic contribution of our acquisitions (+6.1%)

Since October, our French teams have been offering Day 1, a new application that allows French veterinarians and farmers to monitor and compare colostrum quality on the farm. A valuable decision-making aid to improve herd health!